The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Tue., Aug. 9, 3:35 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #54. STERIS Corporation Integrated Medical Systems International, Inc.

Acquirer: STERIS Corporation (NYSE:STE)
Acquiree: Integrated Medical Systems International, Inc.
Details: STERIS Corporation (NYSE:STE) today announced a definitive agreement to acquire Integrated Medical Systems International, Inc. (IMS) for a purchase price of approximately $165 million, plus approximately $10 million for the purchase of real estate. IMS, a privately held business, is an endoscope repair, surgical instrument management and sterile processing consulting company. IMS revenue for the current calendar year is anticipated to be approximately $150 million.

STERIS is a provider of products and services which focused on infection prevention. Co.'s business segments are: Healthcare, which provides infection prevention and procedural products and services, including consumable products and equipment maintenance and installation services; Applied Sterilization Technologies, which provides contract sterilization and testing services for medical device and pharmaceutical manufacturers; Life Sciences, which provides consumable products, equipment maintenance, other services and capital equipment; and Dental, which provides instruments, infection prevention consumables and instrument management systems dental practitioners and dental schools.

STE SEC Filing Email Alerts Service


Open the STE Page at The Online Investor »

Company Name: 
STERIS plc (Ireland)
Website: 
www.steris-ir.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding STE: 
94
Total Market Value Held by ETFs: 
$3.43B
Total Market Capitalization: 
$20.82B
% of Market Cap. Held by ETFs: 
16.48%
 

Open the STE Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree STE Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.80 out of 4)
63rd percentile
(ranked higher than approx. 63% of all stocks covered)

Analysts' Target Price:
STE Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 54 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.